Andreas Kuhn

Andreas Kuhn

Company: BioNTech

Job title: Senior Vice President - RNA Biochemistry & Manufacturing

Seminars:

Adapting the COVID-19 Vaccine to New Sequence Variants 11:30 am

• mRNA is not only well suited for fast development of a vaccine for an emerging pandemic, but also in case of new virus variants • This was put to a challenge with the emergence of the highly transmissive SARS-CoV-2 omicron variant • The experience to switch as fast as possible and the biggest hurdles…Read more

day: Day One

Breakfast Panel: What does the Future Landscape of Next Generation RNA Therapeutics Look Like? 9:00 am - 9:30 am

• What are considered as next generation RNA therapeutics and where is innovation expected to come from? • Lessons learned from the first ever approved/authorized mRNA-based vaccine • Upcoming challenges for the next wave of mRNA-based vaccine and next generation RNA therapeutics • New technologies for further improvements of mRNA therapeutics to achieve proof of…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.